2013Journal of Tissue Engineering and Reconstructive SurgeryRequires access

Transplantation of Human Umbilical-Cord Mesenchymal Stem Cells in Treatment of Cerebellar Atrophy

Zhifang Xu

Open publisher page 0 citations

Abstract

Objective To evaluate the clinical effectiveness of transplantation of human umbilical-cord mesenchymal stem cells(hUMSCs) in the treatment of cerebellar atrophy(CA).Methods The mesenchymal stem cells(MSCs) were separated from umbilical-cord of healthy newborn and were cultured to a large amount in vitro.Then hUMSCs were transplanted(cell amount: 1.0×108) into CA patients(57 cases) by intra-dural injection(2.5×107/5 mL) and intravenous injection(7.5×107/100 mL).Results All the patients were followed up for 6 months.The effective rate were 72.0% 3 months after transplantation and 79.0% 6 months after transplantation respectively.No complication were observed.Conclusion hUMSCs treating CA is safe and effective,but its long-term effectiveness should be further observed.

About this research paper

What this paper is about

Objective To evaluate the clinical effectiveness of transplantation of human umbilical-cord mesenchymal stem cells(hUMSCs) in the treatment of cerebellar atrophy(CA).Methods The mesenchymal stem cells(MSCs) were separated from umbilical-cord of healthy newborn and were cultured to a large amount in vitro.Then hUMSCs were transplanted(cell amount: 1.0×108) into CA patients(57 cases) by intra-dural injection(2.5×107/5 mL) and intravenous injection(7.5×107/100 mL).Results All the patients were followed up for 6 months.The effective rate were 72.0% 3 months after transplantation and 79.0% 6 months after transplantation respectively.No complication were observed.Conclusion hUMSCs treating CA is safe and effective,but its long-term effectiveness should be further observed.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To evaluate the clinical effectiveness of transplantation of human umbilical-cord mesenchymal stem cells(hUMSCs) in the treatment of cerebellar atrophy(CA).Methods The mesenchymal stem cells(MSCs) were separated from umbilical-cord of healthy newborn and were cultured to a large amount in vitro.Then hUMSCs were transplanted(cell amount: 1.0×108) into CA patients(57 cases) by intra-dural injection(2.5×107/5 mL) and intravenous injection(7.5×107/100 mL).Results All the patients were followed up for 6 months.The effective rate were 72.0% 3 months after transplantation and 79.0% 6 months after transplantation respectively.No complication were observed.Conclusion hUMSCs treating CA is safe and effective,but its long-term effectiveness should be further observed.

Key concepts: Umbilical cord, Mesenchymal stem cell, Transplantation, Medicine, Surgery, Stem cell, Atrophy, Pathology

Related papers

Back to paper searchBrowse research topicsOriginal source
Transplantation of Human Umbilical-Cord Mesenchymal Stem Cells in Treatment of Cerebellar Atrophy — Research Paper | ScholarLens